Tag Archives: EASD

7 International Congresses that Are Taking Place this Fall in the Medical World

The Annual Congress of European Respiratory Society (ERS 2018)

The ERS International Congress will take place in Paris, between 15-19 September. It is considered to be the largest meeting dedicated to respiratory professionals in the world. The scientific and educational programme caters to the needs of researchers, clinicians, general practitioners and allied health professionals alike.

For up-to-date information related to the ERS Congress, visit their website.

For accommodation offers – over 615 rooms in 20 exceptional hotels – visit our website.

 

The 18th European Society of Retina Specialists Congress (EURETINA 2018)

This year, the EURETINA Congress will take place in Vienna, between 20-23 September. EURETINA was established as a society dedicated to promoting knowledge among vitreoretinal and macula specialists in 1999. Their first congress took place in 2001 when it had around 200 participants, reaching over 5000 participants in recent years.

For up-to-date information related to the EURETINA Congress, visit their website.

For accommodation offers – over 460 rooms in 12 exceptional hotels – visit our website.

 

The 36th Congress of The European Society of Cataract and Refractive Surgeons (ESCRS 2018)

The 36th Congress of the ESCRS will take place between 22 – 26 September, in Vienna, Austria.

Founded in 1991, the ESCRS has since then promoted education and research in the field of implant and refractive surgery, as well as the study and practice of ophthalmology. ESCRS has over 7,500 members from 130 countries worldwide.

For up-to-date information related to the ESCRS Congress, visit their website.

For accommodation offers – over 360 rooms in 11 exceptional hotels – visit our website.

 

The 54th European Association for the Study of Diabetes Annual Meeting (EASD 2018)

The 2018 edition of the EASD Congress takes place between 1 – 5 October in Berlin, Germany.

The European Association for the Study of Diabetes (EASD) was founded in 1965 as a non-profit, medical scientific association. It is one of the largest networks for diabetologists worldwide with more than 5,000 active members from over 100 countries. EASD’s Annual Meeting takes place in a different European city each year with more than 15,000 delegates from over 130 countries attending.

For up-to-date information related to the EASD Congress, visit their website.

For accommodation offers – over 765 rooms in 16 exceptional hotels – visit our website.

 

The 34th European Committee for Treatment and Research in Multiple Sclerosis Congress (ECTRIMS 2018)

Between 10-12 October, in Berlin, Germany, ECTRIMS hosts the world’s largest annual international conference around basic and clinical research in multiple sclerosis.

For up-to-date information related to the ECTRIMS Congress, visit their website.

For accommodation offers – over 670 rooms in 11 exceptional hotels – visit our website.

 

The European Society for Medical Oncology Congress (ESMO 2018)

The ESMO 2018 Congress will take place between 19-23 October in Munich, Germany.

ESMO was founded in 1975 and has since become the leading European professional organisation for medical oncology, with over 18,000 oncology professionals from more than 150 countries.

For up-to-date information related to the ESMO Congress, visit their website.

For accommodation offers – over 1102 rooms in 21 exceptional hotels – visit our website.

 

The 26th United European Gastroenterology Week (UEGW 2018)

The UEG Week will take place between 20-24 October, in Vienna, Austria. Multidisciplinarity is a key focus of UEG Week, which covers topics of interest for the entire GI community.

The United European Gastroenterology is a professional non-profit organisation combining all the leading European societies concerned with digestive health – more than 25,000 specialists from every field in gastroenterology.

For up-to-date information related to the UEG Week, visit their website.

For accommodation offers – over 365 rooms in 8 exceptional hotels – visit our website.

 

logo-congress bookers

About Congress Bookers

In the world of MICE (Meetings, Incentives, Conferences and Events), Congress Bookers provides a whole range of services needed to organize a group for a medical congress. On our website, you will find a full list of hotel allotments for the most important medical congresses in 2018, regardless of their location. We operate internationally!

Advertisements

Top Medical Congresses to Attend in Germany in 2018

According to a new report published by Allied Market Research, the global MICE industry was valued at USD 752 billion in 2016, and is projected to reach USD 1,245 billion in 2023, registering a CAGR of 7.5% from 2017 to 2023.

In 2016, Europe dominated the global market with more than 42% market share, in terms of value. Medical events have played an important part.

In 2018, Germany will host some of the biggest medical events in Europe: EAACI 2018, ESC 2018, EASD 2018, ECTRIMS 2018, ESMO 2018.

 

The European Academy of Allergy and Clinical Immunology Annual Congress | 26-30 May

The 2018 edition will take place in Munich, Germany at the ICM – Internationales Congress Center München.

The EAACI Congress is organised by the European Academy of Allergy and Clinical Immunology (EAACI), and provides attendees with a one of a kind opportunity to learn more about the latest discoveries in the field of allergy, asthma and clinical immunology.

Munich is seen as one of the most research-focused cities in Germany. It’s well-known for important advances through R&D and innovation centres, being an environment which encourages proactive development work and close cooperation among clinics, universities and research organizations.

Book your accommodation for EAACI 2018 at one of the best hotels in Munich!

 

The 54th European Association for the Study of Diabetes Annual Meeting | 1-5 October 2018

EASD’s 2018 congress will take place in Berlin, Germany at the Messe Berlin Exhibition Halls in Berlin-Charlottenburg.

The European Association for the Study of Diabetes (EASD) was founded in 1965 as a non-profit, medical scientific association, based in Duesseldorf, Germany.

Nowadays, EASD is one of the largest networks for diabetologists worldwide with more than 5,000 active members from over 100 countries. EASD holds its Annual Meeting in a different European city each year with more than 15,000 delegates from over 130 countries attending. The scientific programme includes more than 1,200 talks and presentations on the latest results in diabetes research by leading experts in the field.

Berlin is an international city that has a long-standing tradition of more than 300 years in medical research.The city boasts extraordinary architecture, a mix of historical buildings and contemporary design. Known for its young and experimental spirit, Berlin has always been home to an active and unique art scene.

Book your accommodation for EASD 2018 at one of the best hotels in Berlin!

 

The 34th European Committee for Treatment and Research in Multiple Sclerosis Congress | 10-12 October

The 34th Congress of the ECTRIMS will take place in the bustling and lively European city of Berlin at the City Cube Messe.

As a non-profit organisation, ECTRIMS is Europe’s and the world’s largest professional organisation dedicated to the understanding and treatment of Multiple Sclerosis (MS). Its goal is to improve basic and clinical research and clinical outcomes in MS by creating a network of researchers and clinicians and partnering with other organisations that share similar missions and objectives.

Some of the topics covered in the Scientific Programme of the 2018 edition are: Treatment of relapsing and progressive MS, Risk management with MS therapies, Immunopathology of MS, Molecular imaging, and many more.

Book your accommodation for ECTRIMS 2018 at one of the best hotels in Berlin!

 

The European Society for Medical Oncology Congress | 19-23 October

The ESMO 2018 Congress will take place between 19-23 October 2018, in Munich, Germany at Messe Munich.

ESMO was founded in 1975 and is now the leading European professional organisation for medical oncology. Comprising 17,000 oncology professionals from over 150 countries, ESMO is the network of reference for oncology education and information worldwide.

The programme for the 2018 edition is available online here.

Book your accommodation for ESMO 2018 at one of the best hotels in Munich!
cb-01

About Congress Bookers

In the world of MICE (Meetings, Incentives, Conferences and Events), Congress Bookers provides a whole range of services needed to organize a group for a medical congress. On our website, you will find a full list of hotel allotments for the most important medical congresses in 2018, regardless of their location. We operate internationally!

  • EASL 2018 – 210 rooms in seven 4-star hotels
  • EAACI 2018 – 615 rooms in fourteen 4-star hotels
  • EHA 2018 – 1200 rooms in thirty 4-star hotels
  • ERS 2018 – 615 rooms in twenty 4-star hotels
  • EURETINA 2018 – 460 rooms in twelve 4-star hotels
  • EASD 2018 – 765 rooms in sixteen 4-star hotels
  • ECTRIMS 2018 – 620 rooms in ten hotels
  • ESMO 2018 – 1092 rooms in twenty-one 4-star hotels.

Let’s Meet at ESMO, ERS, EASD and EADV Congresses in September

These are last month’s pharma news and developments brought to you by Congress Bookers, a reliable accommodation partner for lead pharma companies worldwide.

We’ve finished drafting the agenda for the last 4 months of 2017. Time flies, doesn’t it? 🙂

 

In September, we will be on-site at the biggest and most well-known medical congresses in Europe: ESMO 2017, the ERS International Congress, EASD 2017 and the 26th EADV Congress. Congress Bookers will be there to showcase its booking offers for medical congresses in 2018 and beyond. If you also happen to be present at any of these congresses, let’s meet!

Now, here’s some information regarding the above mentioned congresses:

ESMO 2017 – 8-12 September | Madrid, Spain

Bringing together cancer researchers and clinicians, the ESMO 2017 Congress is being held in partnership with the European Association for Cancer Research (EACR). ESMO is considered to be “the most influential annual meeting for oncology professionals in Europe.”

You can see the online programme here.

 

ERS International Congress 2017 – 9-13 September | Milan, Italy

The ERS International Congress is considered to be “the largest meeting of respiratory professionals in the world.” Its scientific and educational programme addresses the needs of researchers, clinicians, general practitioners and health professionals worldwide.

You can see the online programme here.

 

EASD 2017 – 11-15 September | Lisbon, Portugal

The European Association for the Study of Diabetes (EASD) is a non-profit, medical scientific association founded in 1965 and headquartered in Duesseldorf, Germany. EASD holds its Annual Meeting in a different European city each year. Over 15,000 delegates from over 130 countries attend the event. The scientific programme includes presentations on the latest results in diabetes research.

You can see the online programme here.

 

The 26th EADV Congress – 13-17 September | Geneva, Switzerland

EADV was founded in 1987 as a non-profit association. Its mission is to advance excellence in clinical care, research, education and training in the fields of Dermatology and Venereology.

Every year, EADV organizes one main congress in one of the European capital cities and one spring meeting.

You can see the online programme of its 26th Congress here.

See you there!
cb-01

Congress Bookers provides a whole range of services needed to organize a group for a medical congress. On our website, you will find a full list of hotel allotments for the most important medical congresses in 2017 and 2018, regardless of their location. The biggest congresses next year are:

  • EASL 2018 – 210 rooms in seven 4-star hotels
  • EAACI 2018 – 615 rooms in fourteen 4-star hotels
  • EHA 2018 – 1200 rooms in thirty 4-star hotels
  • ERS 2018 – 615 rooms in twenty 4-star hotels
  • EURETINA 2018 – 460 rooms in twelve 4-star hotels
  • EASD 2018 – 765 rooms in sixteen 4-star hotels
  • ECTRIMS 2018 – 620 rooms in ten hotels
  • ESMO 2018 – 1092 rooms in twenty-one 4-star hotels.

3 Reasons to Attend EASD’s Annual Meeting in 2017

The European Association for the Study of Diabetes (EASD) was founded in 1965 as non-profit, medical scientific association based in Duesseldorf, Germany. The Association’s main goal is to support and encourage research in the field of diabetes.

EASD has more than 5,000 active members from over 100 countries worldwide which makes it  one of the largest networks for diabetologists across the globe. Its Annual Meeting is held in a different European city each year. In 2017, the 53rd Annual Meeting of the European Association for the Study of Diabetes will take place in Lisbon, between 11-15 September 2017.

Is the 53rd Annual Meeting of the European Association for the Study of Diabetes on your list in 2017 or/ and 2018? Give us a sign and we’ll handle your accommodation needs in a fast and reliable way!

For 2017.

For 2018.

 

EASD’s Annual Meeting is the Biggest Event of Its Kind

Over 15,000 delegates from more than 130 countries are attending EASD’s Annual Meeting every year. The scientific programme includes over 1,200 talks and presentations on the latest results in diabetes research by leading experts in the field. The Annual Meeting represents a great opportunity for physicians to learn more about diabetes and related diseases, for pharma companies to promote their products and for hotel brokers to showcase their offers. The event is a great opportunity to encounter new vendors and suppliers at the trade show exhibit hall.

 

The Programme Tackles the Hottest Topics in the Field

We’ve visited the event’s website and went through their Programme at a Glance section for the 2017 Annual Meeting. Some key topics that will approached during this year’s event are the following:

  • Management of type 2 diabetes with basal insulin revisited: results of the glargine 300 U/ml Real Life Study Program
  • Cardiovascular complications of diabetes: hot topics
  • Intergenerational transmission of obesity and diabetes: Is the fog being cleared?
  • The beta cell in type 2 diabetes: What are the changes and are they reversible?
  • Molecular transducers of metabolic benefits of exercise
  • Diabetes, obesity, their treatment and cancer risk: smoke or fire?
  • Cognitive impairment and Alzheimer’s disease in the type 2 diabetes patient: from basic science to treatment
  • Genome editing principle and practice: Is there opportunity for diabetes?

 

It’s a Great Opportunity to Visit Lisbon

Successful people know how to mix business with pleasure. It would be a pity to be in Lisbon for the 53rd Annual Meeting of the European Association for the Study of Diabetes and not visit this wonderful city.

Lisbon is Europe’s second oldest capital, predating other modern European capitals such as London, Paris and Rome by centuries. Lisbon is also where the world’s first diabetes association was created in 1926 by Ernesto Roma. You will be enchanted by its rich history, great architecture, old monuments and wonderful landscape. Lisbon is surrounded by beaches, mountains and the countryside. The view is amazing!

Here’s a list with some of the things that you can visit in Lisbon:

  • Saint George’s Castle, a major landmark that can be seen from anywhere in the city.
  • Jerónimos Monastery, a monastery of the military Order of Saint Jerome, an outstanding example of late-Gothic Manueline architecture and is a UNESCO site.
  • Belém Tower, a defense tower completed in 1520 during the reign of Manuel I.
  • Time Out Market Lisboa, home to 35 permanent stalls from some of Lisbon’s most celebrated foodie shops and restaurants.
  • Lisbon Oceanarium, the largest indoor aquarium in Europe.

 

That being said, we hope you’ll enjoy attending EASD’s Annual Meeting in 2017!

Contact us for a personalized accommodation offer for the 53rd Annual Meeting of the European Association for the Study of Diabetes. No strings attached. We usually reply within a few hours.

For 2017.

For 2018.

5 Things to Do in Lisbon During EASD 2017

The 53rd Annual Meeting of the European Association for the Study of Diabetes (EASD) will take place in Lisbon, Portugal, between 11-15 September 2017.

Scientists, physicians, laboratory workers, nurses and students from all over the world will be attending this event to learn more and stay on top of the latest developments and innovations regarding diabetes, metabolism and related subjects.

Besides networking opportunities, attendees will have the chance to address the most applicable problems and solutions related to the diagnosis, treatment, and management of diabetes.

For those of you attending EASD 2017, we’ve compiled a list of 5 things to do while in the beautiful city of Lisbon.

 

Visit Jerónimos Monastery

jeronimos

Situated near the Tagus river in the parish of Belém, Jerónimos Monastery was founded in 1501 and is a monastery of the Order of Saint Jerome.

The monastery stands as a magnificent example of the Manueline style of architecture. It was classified a UNESCO World Heritage Site in 1983.

Manueline architecture is unique to Portugal and combines Flamboyant Gothic, Moorish, and early Renaissance influences. Sculptural detail and maritime motifs are oftentimes being used and are considered characteristic elements of this type of architecture. Other Manueline architecture structures in Portugal include Batalha Monastery and the Templar Convento de Cristo in Tomar.

At Jerónimos Monastery, visitors can see the tombs of King Manuel and other figures who played an important part in Portuguese history, such as Vasco de Gama, the romantic poet Herculano and the poet Fernando Pessoa.

 

Take a walk and drink coffee on the Rossio Square

rossio_square_lisbon

This is one of the most beautiful places to see in Lisbon. Rossio Square is the popular name of the Pedro IV Square and it’s located in the Pombaline Downtown of Lisbon. It has been the city’s most popular square since the Middle Ages. What used to be the place for popular riots and celebrations, bullfights and executions, is now a preferred meeting place for both locals and tourists alike.

One of Rossio Square’s top attractions is the bronze statue of Dom Pedro IV, a former king of Portugal and the first emperor of Brasil.

On the opposite sides of Rossio Square are two baroque-style fountains, while at the northern part of the square, visitors can see and explore the Dona Maria II National Theater.

 

Admire the Belém Palace

portugal-belem-lisbon

The Belém Palace is located in the civil parish of Santa Maria de Belém, on a small hill that fronts the Praça Afonso de Albuquerque, near the historical centre of Belém and the Monastery of the Jeronimos. With its five buildings dating back to the second half of the 17th century,

the palace has been the official residence of Portuguese monarchs and, after the installation of the First Republic, the Presidents of the Portuguese Republic.

Discover the city on a bike

fun-track

Fun Track is a large open space on the Passeio Marítimo de Alcântara, behind the Museu do Oriente where you can rent karts, bicycles, or roller skates to travel on the 7km of cycle path that runs along the river between Belém and Cais do Sodré.

Get your legs moving and lift your tourist spirit high!

 

Admire the view from the 25th April Bridge

25th-april-bridge

Seen as the twin sister of the Golden Gate Bridge in San Francisco, the 25th April Bridge stretches across the estuary at the Tagus River in Lisbon. It was built in 1996 and it currently represents the largest suspension bridge in Europe and the 20th longest in the world.

The bridge is approximately 2.3 km long and stands over 70 metres above the water. It will give any visitor a breathtaking view of the city of Lisbon!

 

These were our top five picks when it comes to things you could do and see in Lisbon during EASD. That being said, book your accommodation for EASD 2017 today and start working on planning your trip.

Our offer comprises the following 4-star hotels:

  • NH Collection Lisboa Liberdade
  • VIP Executive Diplomatico Hotel
  • VIP Executive Villa Rica Hotel
  • Tivoli Oriente Hotel
  • My Story Hotel Ouro
  • Neya Hotel
  • Hotel Florida

 

Top Trends that Will Dominate the Pharma Sector in 2017

We’re soon saying goodbye to 2016, a bustling year for pharma in terms of technology, innovations, as well as mergers and acquisitions. Big companies saw important breakthroughs, new drugs have been approved by the FDA and important lawsuits have been gained. All in all, an exciting year for the pharma and healthcare industry.

pharmatrends

Now is the time to look at 2016 and understand which important trends from 2016 will pick up next year and what their influence will be.

 

Drug prices will still be heavily debated

Drug prices have made headlines over the past few years (they were even an election issue in the US) and will continue to do so throughout 2017.

Dr. Carole Bruckler, Senior Advisor at Allied World Healthcare, predicted that “2017 will be a year where ongoing trends will crystalize further,” and that  “in the US, there is clear political will forming against annual or quarterly drug price increases to fuel sales growth.”

Although a Clinton victory would have meant high drug prices, Donald Trump’s election in the US doesn’t mean that the pharma industry is out of hot water yet. His plans to have uniform pricing schemes could highly impact profit margins and may even mean a change in pharma’s existing business models.

 

Patients will hold the power

It seems that those days when patients would go to the doctor whenever they got sick to have medication prescribed are gone. Nowadays, patients are empowered. They have access to huge amounts of information online and can learn about their health conditions. When dealing with mild symptoms, they can even use the information that they find to choose from various treatment alternatives. This means that, in many instances, doctors cannot influence patients’ choices anymore. Therefore, pharma companies have to start looking for new ways to get their medications sold.

When it comes to empowered patients, pharma and healthcare companies need to understand that, thanks to technology and the opportunities it provides, their expectations are high. If they are not provided with an immediate solution, they know they always have an alternative.

Smartwatches like Apple Watch or Samsung Gear and fitness bands (FitBit, Jawbone, Garmin) have sensors capable of taking biometric readings. As they become more advanced, wearable devices will become a key asset in gathering clinical trial data remotely in real-time but also in helping patients monitor their health without the need for a doctor or nurse.

 

Tech giants are here to stay

Over the past few years, pharma companies have witnessed the entry and involvement of

tech companies such as Google, Apple and IBM. The latter can help collect and process massive amounts of health-related, thus helping pharma companies gain a better understanding of diseases, broaden their R&D strategies and find the right treatments.

Google’s Alphabet hosts several separate firms, including Google Ventures, Google X and Calico. All three of them are focusing on drug development. Calico tackles aging-related diseases such as Alzheimer’s, and Google Ventures increased its funding of healthcare-related ventures. Not to be left out is Google’s partnership with Novartis to develop “smart contacts” for age-related degeneration in eyesight.

Meanwhile, IBM and Apple have teamed up with Medtronic and Johnson & Johnson to carefully leverage clinical trial data to create better targeted therapies for patients, while ensuring the latter’s compliance with their drugs. Apple’s HealthKit and ResearchKit technologies are complementing such partnerships, as is IBM’s supercomputer Watson.

 

Artificial intelligence might become a game changer in the near future

Using the power of AI and supercomputers for medical decision making purposes will definitely change everyday medicine. Cognitive computing platforms such as IBM Watson have the capabilities to interact in natural language, process vast amounts of Big Data and understand patterns and insights while learning from each interaction. By digesting and interpreting millions of pages of scientific literature, IBM Watson can assist pharma companies in the development of new drugs while repurposing existing ones.

The fact that cognitive computers have been used to analyse big data, not only in genomic research but also in biotechnology, might change the way new drugs are found. The era of human experimentation might come to an end and be replaced by the era of detailed simulation of human physiology. Instead of being tested on people, drugs could be tested by supercomputers on billions of simulations modelling the physiology of the human body in a matter of seconds. This won’t happen in 2017 since it’s much too soon but it’s something that pharma should support and look into throughout the next couple of years.

These were our top picks for trends that will continue to dominate the pharma sector in 2017 and beyond. Of course, they are not set in stone. As technology advances, many great things and innovations will emerge.

 

Congress Bookers provides a whole range of services needed to organize a group for a medical congress. On our website, you will find a full list of hotel allotments for the most important medical congresses in 2017, regardless of their location. The biggest congresses next year are:

From 60 Pharma companies to 10 Big Pharma companies in 20 Years

We’ve all heard about Novartis, Pfizer, Sanofi and Roche. They’re some of the big guys in the pharma landscape, enjoying increased popularity, splitting the high budgets and revolutionizing the healthcare and pharma industry but what’s the road they took to get here? In order to answer that question, we’re going to analyze the 10 biggest pharma companies nowadays which used to be around 60 distinct companies 20 years ago. Here’s what they did to stand the test of time and grow.

best-pharmaceutical-companies

Novartis

It all dates back to 1970 when Ciba-Geigy was formed by the merger of J. R. Geigy Ltd and CIBA. In 1996, from the merger of Ciba-Geigy and Sandoz Laboratories, Novartis was born. In 2005, Novartis acquired Hexal and Eon Labs, thus growing its generic division Sandoz. A year later, in 2006, Novartis acquired full control of Chiron Corp. for USD 5.1 billion. In 2010, Novartis acquired the world’s largest eye-care company Alcon for USD 39.3 billion. Three years later, in 2012, the company bought Fougera Pharmaceuticals for USD 1.5 billion. In 2016, Novartis acquired Selexys Pharmaceuticals Corporation and SelG1 antibody for reduction of pain crises in sickle cell disease (SCD).

AstraZeneca (AZ)

AstraZeneca  was created in 1999 following the merger of Astra and Zeneca Group. In 2004, AZ completed its first big acquisition of Cambridge Antibody Technology. Later on, in 2007, it acquired MedImmune for about USD 15.2 billion. In 2012, AstraZeneca acquired Ardea Biosciences for USD 1.3 billion. One year later, it acquired Amylin from BMS for USD 4.3 billion and in 2015 acquired ZS Pharma for USD 2.7 billion. In 2015, AstraZeneca bought 55% majority stake in Acerta for USD 4 billion.

Pfizer

In 2000, Pfizer acquired American pharmaceutical company Warner–Lambert for USD 111.8 billion to bring its drug, Lipitor, to market. In 2002, Pfizer aimed to acquire full rights to Pharmacia’s product Celebrex and thus agreed to buy Pharmacia for stock valued at USD 60.0 billion. In 2009, Pfizer bought pharmaceutical company Wyeth for USD 68.0 billion. In 2015, Pfizer acquired Hospira for USD 15.2 billion and announced the merger with Allergan. The latter is considered to be one of the biggest mergers in pharma history. In 2016, Pfizer announced the successful completion of its acquisition of Medivation.

Sanofi

Sanofi resulted from the merger between Sanofi-Synthélabo and Aventis in 2004. The former was created in 1999 when Sanofi merged with Synthélabo. Aventis was formed in 1999 following the merger of Rhône-Poulenc S.A. with Hoechst Marion Roussel (HMR). The latter itself was formed in 1995 from the merger of Hoechst AG with Cassella, Roussel Uclaf and Marion Merrell Dow.

In 2011, Sanofi-Aventis acquired Genzyme and changed its name to Sanofi.

Johnson & Johnson

J&J was founded in 1886 as a medical devices, pharmaceutical and consumer packaged goods company. The pharmaceutical division is made up of Janssen & Cilag. In 2006, Janssen acquired the consumer healthcare business of Pfizer for USD 16.6 billion in what is considered to be the company’s largest M&A deals. In 2013, the company acquired Aragon Pharma and in 2014 it bought Alios BioPharma, Inc. for USD 1.75 billion.

Merck & Co.

Merck was founded in 1668 and is the world’s oldest operating chemical and pharmaceutical company. Merck & Co. was established as a subsidiary of Merck in 1891, but became an independent company in 1917. It is known as MSD (Merck Sharp and Dohme) outside of North America. In 1993, Merck purchased Medco Containment Services Inc. for USD 6 billion. In 2009, Merck merged with Schering-Plough. The latter had acquired Organon from Akzo Nobel in 2007 while Organon resulted from a merger between Diosynth and Organon in 2004. Ten years later, Merck bought Cubist Pharmaceuticals for USD 8.4 billion.

Roche

Roche’s first acquisition took place in 1994 when the company bought Syntex Corporation for USD 5.3 billion. In 2002, Roche’s Japanese subsidiary Nippon Roche merged with Chugai. Following the deal, Roche got a majority stake in the Japanese company. In 2008, Roche acquired Ventana Medical Systems for USD 3.4 billion and in 2009, the company bought Genentech for USD 46.8 billion.

Teva

Teva resulted from the merger between Assia, Zori and Teva in 1976. In 2006, Teva completed its first big acquisition of IVAX Corporation for USD 7.4 billion. In 2011, it acquired Cephalon for USD 6.8 billion. After acquiring Auspex Pharma for USD 3.5 billion in 2015, Teva completed its acquisition of Allergan’s generics business (“Actavis Generics”) in 2016.

Gilead Sciences

Gilead Sciences was founded in June 1987. Over the past 16 years, the company has made several acquisitions. The biggest ones include: CV Therapeutics for USD 1.4 billion in 2009 and USD 10.4 billion acquisition of Pharmasset in 2011.

GlaxoSmithKline (GSK)

GSK was founded in 2000 following the merger of Glaxo Wellcome and SmithKline Beecham. In 2001, GSK acquired Block Drug for USD 1.2 billion. In 2009, GSK acquired Stiefel Laboratories for USD 3.6 bn. 4 years later, in 2013, GSK acquired Human Genome Sciences (HGS) for USD 3 billion. In 2015, GSK completed the acquisition of vaccine business of Novartis and sale of its oncology business to the Swiss drug major in a global deal. Under the agreement, GSK Pharma expanded its vaccine portfolio and took over 120 employees from Novartis to boost its sales in India.

There’s so much pharma history behind all of the big names out there and the evolution is far from reaching an end. We’re looking forward to seeing what these pharma giants have in store during the next couple of years and who’s going to lead the way in the M&A sector.

Congress Bookers provides a whole range of services needed to organize a group for a medical congress. On our website, you will find a full list of hotel allotments for the most important medical congresses in 2017, regardless of their location. The biggest congresses next year are: